# PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK

> **NCT03511326** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 50 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** Methyl Aminolaevulinate 16% Cream

## Key facts

- **NCT ID:** NCT03511326
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-07
- **Primary completion:** 2017-11-28
- **Final completion:** 2017-11-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03511326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03511326, "PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03511326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*